Back
Ultra Clean Holdings Vs. Monopar Therapeutics Industry Stock Comparison
Sell
34
UCTT
Ultra Clean Holdings
Last Price:
$25.21
Seasonality Move:
8.12%
Sell
45
MNPR
Monopar Therapeutics
Last Price:
$39.96
Seasonality Move:
-24.75%
Sell
34
Ultra Clean Holdings (UCTT)
is a Sell
Is Ultra Clean Holdings a Buy, Sell or Hold?
-
The current Ultra Clean Holdings [UCTT] share price is $24.91. The Score for UCTT is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
-
UCTT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
45
Monopar Therapeutics (MNPR)
is a Sell
Is Monopar Therapeutics a Buy, Sell or Hold?
-
The current Monopar Therapeutics [MNPR] share price is $34.37. The Score for MNPR is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
-
MNPR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
UCTT Stock Price Chart
What is Ultra Clean Holdings's stock price today?
-
The Ultra Clean Holdings share price today is $24.91Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and UCTT is experiencing selling pressure, which indicates risk of future bearish movement.
MNPR Stock Price Chart
What is Monopar Therapeutics's stock price today?
-
The Monopar Therapeutics share price today is $34.37Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MNPR is experiencing buying pressure, which is a positive indicator for future bullish movement.
UCTT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.95 | Sell |
Relative Strength Index (14 RSI): | 36.49 | Sell |
Chaikin Money Flow: | -297878 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (23.43 - 36.55) | Sell |
Bollinger Bands (100): | (30.47 - 39.65) | Sell |
MNPR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.8 | Sell |
Relative Strength Index (14 RSI): | 50.93 | Buy |
Chaikin Money Flow: | 16181 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (29.38 - 44.94) | Sell |
Bollinger Bands (100): | (16.76 - 38.26) | Buy |
UCTT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 24.6 | Buy |
20-day SMA: | 28.05 | Sell |
50-day SMA: | 33.57 | Sell |
200-day SMA: | 38.64 | Sell |
8-day EMA: | 25.06 | Sell |
20-day EMA: | 27.55 | Sell |
50-day EMA: | 31.63 | Sell |
200-day EMA: | 36.36 | Sell |
MNPR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 30.92 | Buy |
20-day SMA: | 34.11 | Buy |
50-day SMA: | 35.31 | Sell |
200-day SMA: | 15.6 | Buy |
8-day EMA: | 32.1 | Buy |
20-day EMA: | 33.86 | Buy |
50-day EMA: | 33.39 | Buy |
200-day EMA: | 20.23 | Buy |
Ultra Clean Holdings Earnings Growth & UCTT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.22 per share, an increase next quarter of $0.24 per share, an increase this year of $0.52 per share, and an increase next year of $1.09 per share.
Monopar Therapeutics Earnings Growth & MNPR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.50 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.70 per share, and an increase next year of $2.24 per share.
Ultra Clean Holdings Technical Analysis
Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
04 | 05 | 06 | 07 | 11 | 12 | 13 | 14 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Monopar Therapeutics Technical Analysis
Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
04 | 05 | 06 | 07 | 11 | 12 | 13 | 14 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |